<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0"><channel><title>Atualizações ICAM - Tratamento</title><link>https://icam.org.pt/actualizacoes/tratamento/rss.xml</link><description>Sinopses de artigos científicos produzidas pela equipa ICAM.</description><atom:link href="https://icam.org.pt/actualizacoes/tratamento/rss.xml" rel="self"/><docs>http://www.rssboard.org/rss-specification</docs><generator>python-feedgen</generator><language>pt</language><lastBuildDate>Fri, 15 May 2020 16:21:08 +0000</lastBuildDate><item><title>Papel da heparina no tratamento de doentes COVID-19 </title><link>https://icam.org.pt/revisions/?id=382</link><description>Heparin therapy improving hypoxia in COVID-19 patients - a case series Negri et al.  medRxiv preprint  | 22-Apr-2020</description><guid isPermaLink="false">https://icam.org.pt/revisions/?id=382</guid></item><item><title>A anticoagulação reduz a mortalidade em doentes COVID-19 com coagulopatia</title><link>https://icam.org.pt/revisions/?id=383</link><description>Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Tang, et al. Journal of thrombosis and haemostasis : JTH. | 27-Mar-2020</description><guid isPermaLink="false">https://icam.org.pt/revisions/?id=383</guid></item><item><title>COVID-19 - Incidência elevada de complicações trombóticas em doentes na UCI</title><link>https://icam.org.pt/revisions/?id=384</link><description>Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Klok, et al. Thrombosis research. | 10-Apr-2020</description><guid isPermaLink="false">https://icam.org.pt/revisions/?id=384</guid></item><item><title>Considerações da AEMPS sobre a utilização de medicamentos para a COVID-19 </title><link>https://icam.org.pt/revisions/?id=386</link><description>Tratamientos disponibles para el manejo de la infección respiratoria por SARS-CoV-2. Agencia Española del Medicamento y Productos Sanitarios Agencia Española del Medicamento y Productos Sanitarios | 19-Mar-2020</description><guid isPermaLink="false">https://icam.org.pt/revisions/?id=386</guid></item><item><title>Auranofina, um novo medicamento para a COVID-19?</title><link>https://icam.org.pt/revisions/?id=393</link><description>The FDA- approved gold drug Auranofin inhibits novel coronavirus (SARS- COV-2) replication and attenuates inflammation in human cells  Hussin A. Et al. bioRxiv 2020.04.14.041228 | 15-Apr-2020</description><guid isPermaLink="false">https://icam.org.pt/revisions/?id=393</guid></item><item><title>Papel do Tocilizumab no tratamento da COVID-19</title><link>https://icam.org.pt/revisions/?id=396</link><description>Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review. Alzghari and Acuña. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. | 21-Apr-2020</description><guid isPermaLink="false">https://icam.org.pt/revisions/?id=396</guid></item><item><title>Revisão do tratamento farmacológico para a infeção por SARS-CoV-2</title><link>https://icam.org.pt/revisions/?id=400</link><description>Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. Sanders, et al. JAMA. | 13-Apr-2020</description><guid isPermaLink="false">https://icam.org.pt/revisions/?id=400</guid></item><item><title>Associação entre anticoagulantes em dose terapêutica e a ocorrência de eventos hemorrágicos e mortalidade em doentes hospitalizados com COVID-19 </title><link>https://icam.org.pt/revisions/?id=410</link><description>Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19. Paranjpe, et al. Journal of the American College of Cardiology. | 05-May-2020</description><guid isPermaLink="false">https://icam.org.pt/revisions/?id=410</guid></item><item><title>Anticorpo monoclonal humano bloqueia a infeção por SARS-CoV-2</title><link>https://icam.org.pt/revisions/?id=411</link><description>A human monoclonal antibody blocking SARS-CoV-2 infection. Wang, et al. Nature communications. | 04-May-2020</description><guid isPermaLink="false">https://icam.org.pt/revisions/?id=411</guid></item></channel></rss>